ADVERUM BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 13th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Leone Patterson (“Executive”) and Adverum Biotechnologies, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
Leone Patterson Re: Employment Terms for Chief Financial Officer Dear Ms. Patterson:Letter Agreement • June 13th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This letter agreement (the “Agreement”) memorializes the employment terms for your anticipated hire by Adverum Biotechnologies, Inc. (the “Company”) in the position of Chief Financial Officer reporting to Paul Cleveland, Chief Executive Officer. These terms will become effective on June 15, 2016, or at a later date determined by mutual agreement and approved by the Board of Directors of the Company (as applicable, the “Hire Date”).
